Syra Health Corp
Close on Oct 19, 2026
- Market cap
- $11.19M
- P/E (TTM)
- 82.6
- Dividend yield
- –
Earnings
Next report expected Nov 11, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 11, 2026 | Before market open | $2.40M | $0.02 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | Before market open | $2.27M | $0.02 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 12, 2026 | Before market open | – | $-0.01 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 12, 2025 | Before market open | $1.70M | $-0.02 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 12, 2025 | Before market open | $1.95M | $-0.01 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 8, 2025 | After market close | $1.90M | $-0.04 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 11, 2025 | After market close | $2.00M | $-0.05 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 29, 2024 | Before market open | $2.30M | $-0.06 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 9, 2024 | After market close | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 9, 2024 | After market close | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 25, 2024 | After market close | – | – | – |
Press releases
Announcements Syra Health filed with the SEC
Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter
Results of operations · EX-99.1 to Form 8-K
Health Delivers its First Profitable Quarter in Q1 2026, Expands Margins and Strengthens Financial Position
Results of operations · EX-99.1 to Form 8-K
Health Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026
Results of operations · EX-99.1 to Form 8-K
Health Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth
Executive or director change · Other events · EX-99.1 to Form 8-K
Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve
Results of operations · EX-99.1 to Form 8-K
Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions
Results of operations · EX-99.1 to Form 8-K
Health Board Begins CEO Search to Drive Growth
Other events · EX-99.1 to Form 8-K
Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY
Results of operations · EX-99.1 to Form 8-K
Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY
Results of operations · EX-99.1 to Form 8-K
Health Delivers Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Health Announces Second Quarter 2024 Financial Results, Led by Strong Revenue Growth of 101%
Results of operations · EX-99.1 to Form 8-K
Health Announces First Quarter 2024 Financial Results, Led By Strong Revenue Growth of 47%.
Results of operations · EX-99.1 to Form 8-K
Health Announces Fourth-Quarter and Full-Year 2023 Financial Results. Projects 2024 Revenue Growth of 64% to 100%.
Results of operations · EX-99.1 to Form 8-K
Health Announces Third Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Health Corp. Announces Pricing of Upsized Initial Public Offering
Executive or director change · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Health Corp. Announces Closing of Initial Public Offering
Executive or director change · Charter or bylaw amendment · Other events · EX-99.2 to Form 8-K